{"id":157538,"date":"2026-07-17T15:33:16","date_gmt":"2026-07-17T10:03:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=157538"},"modified":"2026-07-17T15:33:17","modified_gmt":"2026-07-17T10:03:17","slug":"vaccine-biologics-manufacturing-stocks-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/","title":{"rendered":"3 Vaccine and Biologics Manufacturing Stocks"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Biocon, Syngene International and Zydus Lifesciences continue expanding vaccine and biologics manufacturing capacity for domestic and global markets.<\/em><\/p>\n<p>Biocon, Syngene International and Zydus Lifesciences are among the vaccine and biologics manufacturing stocks, each positioned within India&#8217;s vaccine and biologics manufacturing growth story through distinct business drivers.<\/p>\n<p>India&#8217;s vaccine and biologics manufacturing sector continues to see sustained investment and demand growth, and vaccine and biologics manufacturing stocks reflects companies with the clearest exposure to this trend.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=vaccine-biologics-manufacturing-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<p>This article examines Biocon, Syngene International and Zydus Lifesciences as vaccine and biologics manufacturing stocks, covering their specific growth drivers and the risks of this theme.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#What_Defines_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"What Defines the 3 Vaccine and Biologics Manufacturing Stocks\">What Defines the 3 Vaccine and Biologics Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Why_These_Are_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"Why These Are the 3 Vaccine and Biologics Manufacturing Stocks\">Why These Are the 3 Vaccine and Biologics Manufacturing Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Biocon_Biosimilars_and_biologics_manufacturing_leadership\" title=\"Biocon: Biosimilars and biologics manufacturing leadership\">Biocon: Biosimilars and biologics manufacturing leadership<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Syngene_International_Contract_research_and_manufacturing_services_relevant_to_vaccine_development\" title=\"Syngene International: Contract research and manufacturing services relevant to vaccine development\">Syngene International: Contract research and manufacturing services relevant to vaccine development<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Zydus_Lifesciences_Pharmaceutical_manufacturing_extending_into_vaccine_and_biologics_production\" title=\"Zydus Lifesciences: Pharmaceutical manufacturing extending into vaccine and biologics production\">Zydus Lifesciences: Pharmaceutical manufacturing extending into vaccine and biologics production<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Factors_Affecting_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"Factors Affecting the 3 Vaccine and Biologics Manufacturing Stocks\">Factors Affecting the 3 Vaccine and Biologics Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Benefits_of_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"Benefits of the 3 Vaccine and Biologics Manufacturing Stocks\">Benefits of the 3 Vaccine and Biologics Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Risks_of_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"Risks of the 3 Vaccine and Biologics Manufacturing Stocks\">Risks of the 3 Vaccine and Biologics Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#How_to_Evaluate_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"How to Evaluate the 3 Vaccine and Biologics Manufacturing Stocks\">How to Evaluate the 3 Vaccine and Biologics Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#How_to_Invest_in_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"How to Invest in the 3 Vaccine and Biologics Manufacturing Stocks\">How to Invest in the 3 Vaccine and Biologics Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"3 Vaccine and Biologics Manufacturing Stocks?\">3 Vaccine and Biologics Manufacturing Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#What_drives_Biocons_growth_in_this_theme\" title=\"What drives Biocon&#8217;s growth in this theme?\">What drives Biocon&#8217;s growth in this theme?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#What_drives_Syngene_Internationals_growth_in_this_theme\" title=\"What drives Syngene International&#8217;s growth in this theme?\">What drives Syngene International&#8217;s growth in this theme?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#What_drives_Zydus_Lifesciencess_growth_in_this_theme\" title=\"What drives Zydus Lifesciences&#8217;s growth in this theme?\">What drives Zydus Lifesciences&#8217;s growth in this theme?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#Is_this_theme_purely_cyclical_or_structural\" title=\"Is this theme purely cyclical or structural?\">Is this theme purely cyclical or structural?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/vaccine-biologics-manufacturing-stocks-2026\/#What_risks_apply_to_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\" title=\"What risks apply to the 3 Vaccine and Biologics Manufacturing Stocks?\">What risks apply to the 3 Vaccine and Biologics Manufacturing Stocks?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Defines_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>What Defines the 3 Vaccine and Biologics Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The vaccine and biologics manufacturing stocks are companies with direct exposure to vaccine and biologics manufacturing, combining relevant scale with disclosed growth or expansion plans.<\/p>\n<p>Understanding these vaccine and biologics manufacturing stocks helps investors identify names positioned to benefit from sustained sector-wide demand rather than one-off catalysts.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_These_Are_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>Why These Are the 3 Vaccine and Biologics Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Biocon&#8217;s biosimilars and biologics manufacturing leadership, Syngene International&#8217;s contract research and manufacturing services relevant to vaccine development and Zydus Lifesciences&#8217;s pharmaceutical manufacturing extending into vaccine and biologics production together explain why these represent the vaccine and biologics manufacturing stocks.<\/p>\n<ul>\n<li><strong>Biocon&#8217;s biosimilars and biologics manufacturing leadership:<\/strong> Biocon&#8217;s its biosimilars and biologics manufacturing leadership, maintaining a strong global pipeline of complex biological drug products.<\/li>\n<li><strong>Syngene International&#8217;s contract research and manufacturing services relevant to vaccine development:<\/strong> Syngene International&#8217;s its contract research and manufacturing services scale, supporting global pharmaceutical and biotech clients with outsourced vaccine and biologics R&amp;D.<\/li>\n<li><strong>Zydus Lifesciences&#8217;s pharmaceutical manufacturing extending into vaccine and biologics production:<\/strong> Zydus Lifesciences&#8217;s its pharmaceutical manufacturing capability, extending into vaccine and biologics production alongside its broader generics and specialty business.<\/li>\n<li><strong>Sustained sector-wide demand:<\/strong> Broader structural demand growth across vaccine and biologics manufacturing supports all three companies within this theme.<\/li>\n<\/ul>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Company<\/th>\n<th>CMP (Rs)<\/th>\n<th>Growth Driver<\/th>\n<th>Sector<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/user\/stocks\/biocon\/biocon-ltd-share-price-today\">Biocon<\/a><\/td>\n<td>&#8211;<\/td>\n<td>Biosimilars and biologics manufacturing leadership<\/td>\n<td>Vaccine<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/user\/stocks\/syngene\/syngene-international-ltd-share-price-today\">Syngene International<\/a><\/td>\n<td>&#8211;<\/td>\n<td>Contract research and manufacturing services relevant to vaccine development<\/td>\n<td>Vaccine<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/user\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\">Zydus Lifesciences<\/a><\/td>\n<td>&#8211;<\/td>\n<td>Pharmaceutical manufacturing extending into vaccine and biologics production<\/td>\n<td>Vaccine<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Biocon_Biosimilars_and_biologics_manufacturing_leadership\"><\/span><strong>Biocon: Biosimilars and biologics manufacturing leadership<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Biocon is among the vaccine and biologics manufacturing stocks, its biosimilars and biologics manufacturing leadership, maintaining a strong global pipeline of complex biological drug products.<\/p>\n<p>Biocon&#8217;s early investment in biosimilar development has positioned it as one of India&#8217;s leading biologics manufacturers for global markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Syngene_International_Contract_research_and_manufacturing_services_relevant_to_vaccine_development\"><\/span><strong>Syngene International: Contract research and manufacturing services relevant to vaccine development<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Syngene International is among the vaccine and biologics manufacturing stocks, its contract research and manufacturing services scale, supporting global pharmaceutical and biotech clients with outsourced vaccine and biologics R&amp;D.<\/p>\n<p>Syngene International&#8217;s integrated research-to-manufacturing services model has attracted long-term partnerships with major global pharmaceutical companies.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Get SEBI-Registered Research on Vaccine Biologics Manufacturing Stocks<\/strong><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_Pharmaceutical_manufacturing_extending_into_vaccine_and_biologics_production\"><\/span><strong>Zydus Lifesciences: Pharmaceutical manufacturing extending into vaccine and biologics production<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Zydus Lifesciences is among the vaccine and biologics manufacturing stocks, its pharmaceutical manufacturing capability, extending into vaccine and biologics production alongside its broader generics and specialty business.<\/p>\n<p>Zydus Lifesciences&#8217; broader pharmaceutical manufacturing expertise provides a foundation for vaccine and biologics product development.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Biocon, Syngene International and Zydus Lifesciences live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Factors_Affecting_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>Factors Affecting the 3 Vaccine and Biologics Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Execution track record:<\/strong> For the vaccine and biologics manufacturing stocks, execution against disclosed plans remains the key determinant of realised growth.<\/li>\n<li><strong>Sector-wide demand trends:<\/strong> Broader demand trends across vaccine and biologics manufacturing affect all three companies collectively.<\/li>\n<li><strong>Competitive intensity:<\/strong> Rising competition within vaccine and biologics manufacturing could pressure margins even amid volume growth.<\/li>\n<li><strong>Input cost and supply chain factors:<\/strong> Cost and supply chain dynamics affect profitability for companies within this theme.<\/li>\n<li><strong>Policy and regulatory support:<\/strong> Government policy support toward vaccine and biologics manufacturing affects the sustainability of this growth theme.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Benefits_of_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>Benefits of the 3 Vaccine and Biologics Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Structural growth theme exposure:<\/strong> The vaccine and biologics manufacturing stocks provide exposure to a sustained, structural growth theme rather than a short-term cycle.<\/li>\n<li><strong>Diversified company selection:<\/strong> Spanning three companies, this list reduces single-stock concentration risk within the theme.<\/li>\n<li><strong>Established execution capability:<\/strong> These companies bring existing scale and expertise to capture growth within vaccine and biologics manufacturing.<\/li>\n<li><strong>Policy-aligned positioning:<\/strong> These stocks align with broader government policy priorities supporting this sector.<\/li>\n<li><strong>Multiple growth vectors:<\/strong> Different business models across these three names offer diversified ways to capture the same broad theme.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Risks_of_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>Risks of the 3 Vaccine and Biologics Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Execution risk:<\/strong> These companies still need to execute disclosed plans successfully to realise growth.<\/li>\n<li><strong>Valuation considerations:<\/strong> Strong recent sector performance means current valuations may already reflect growth expectations for the vaccine and biologics manufacturing stocks.<\/li>\n<li><strong>Competitive pressure:<\/strong> Rising competition within vaccine and biologics manufacturing could affect market share and margins over time.<\/li>\n<li><strong>Cyclicality risk:<\/strong> Demand within vaccine and biologics manufacturing could prove more cyclical than currently anticipated.<\/li>\n<li><strong>Broader market sentiment risk:<\/strong> Overall market conditions can affect these stocks regardless of company-specific fundamentals.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>How to Evaluate the 3 Vaccine and Biologics Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Among the vaccine and biologics manufacturing stocks, compare execution track record against disclosed growth and expansion plans.<\/li>\n<li>For the vaccine and biologics manufacturing stocks, assess competitive positioning within the broader vaccine and biologics manufacturing sector.<\/li>\n<li>Track quarterly results to confirm continued execution progress.<\/li>\n<li>Consider valuation relative to growth visibility for each name.<\/li>\n<li>Combine sector-theme analysis with standard fundamental research.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>How to Invest in the 3 Vaccine and Biologics Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Use the Univest platform to track quarterly results and expansion progress for the vaccine and biologics manufacturing stocks.<\/li>\n<li>Open a demat and trading account with Univest for zero-brokerage execution.<\/li>\n<li>Track quarterly results for Biocon, Syngene International and Zydus Lifesciences through the Univest app.<\/li>\n<li>Consult a SEBI-registered advisor before allocating capital to this theme.<\/li>\n<li>Review positions periodically as execution progress and sector trends evolve.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Biocon, Syngene International and Zydus Lifesciences represent the vaccine and biologics manufacturing stocks, each capturing different aspects of India&#8217;s sustained vaccine and biologics manufacturing growth story. Historically, this structural theme has offered diversified exposure across multiple companies, though execution risk and valuation considerations remain important factors. Consult a SEBI-registered advisor before making investment decisions.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>3 Vaccine and Biologics Manufacturing Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Biocon, Syngene International and Zydus Lifesciences are the vaccine and biologics manufacturing stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_drives_Biocons_growth_in_this_theme\"><\/span><strong>What drives Biocon&#8217;s growth in this theme?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Biocon benefits from biosimilars and biologics manufacturing leadership.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_drives_Syngene_Internationals_growth_in_this_theme\"><\/span><strong>What drives Syngene International&#8217;s growth in this theme?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syngene International benefits from contract research and manufacturing services relevant to vaccine development.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_drives_Zydus_Lifesciencess_growth_in_this_theme\"><\/span><strong>What drives Zydus Lifesciences&#8217;s growth in this theme?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Lifesciences benefits from pharmaceutical manufacturing extending into vaccine and biologics production.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_theme_purely_cyclical_or_structural\"><\/span><strong>Is this theme purely cyclical or structural?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The vaccine and biologics manufacturing stocks represent a structural growth theme, though cyclicality risk remains a consideration.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_apply_to_the_3_Vaccine_and_Biologics_Manufacturing_Stocks\"><\/span><strong>What risks apply to the 3 Vaccine and Biologics Manufacturing Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks include execution risk, valuation considerations, and competitive pressure within the sector.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>3 vaccine and biologics manufacturing stocks, Biocon, Syngene International and Zydus Lifesciences, capture India&#8217;s growing biopharmaceutical production capability.<\/p>\n","protected":false},"author":35,"featured_media":157568,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-157538","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1784282600:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["75"],"rank_math_title":["3 Vaccine and Biologics Manufacturing Stocks"],"rank_math_description":["3 vaccine and biologics manufacturing stocks, Biocon, Syngene International and Zydus Lifesciences, capture India's growing biopharmaceutical production capability."],"rank_math_focus_keyword":["vaccine and biologics manufacturing stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["157568"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["27722"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/3-Vaccine-and-Biologics-Manufacturing-Stocks.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/157538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=157538"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/157538\/revisions"}],"predecessor-version":[{"id":157570,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/157538\/revisions\/157570"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/157568"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=157538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=157538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=157538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}